Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2003
Total Cost
Indirect Cost
Name
Baylor College of Medicine
Department
Type
DUNS #
City
State
Country
Zip Code
Ramani, Sasirekha; Neill, Frederick H; Opekun, Antone R et al. (2015) Mucosal and Cellular Immune Responses to Norwalk Virus. J Infect Dis 212:397-405
Atmar, Robert L; Opekun, Antone R; Gilger, Mark A et al. (2014) Determination of the 50% human infectious dose for Norwalk virus. J Infect Dis 209:1016-22
Katayama, Kazuhiko; Murakami, Kosuke; Sharp, Tyler M et al. (2014) Plasmid-based human norovirus reverse genetics system produces reporter-tagged progeny virus containing infectious genomic RNA. Proc Natl Acad Sci U S A 111:E4043-52
Stadler, Laura Patricia; Bernstein, David I; Callahan, S Todd et al. (2013) Seroprevalence and Risk Factors for Cytomegalovirus Infections in Adolescent Females. J Pediatric Infect Dis Soc 2:7-14
Ajami, Nadim J; Barry, Meagan A; Carrillo, Berenice et al. (2012) Antibody responses to norovirus genogroup GI.1 and GII.4 proteases in volunteers administered Norwalk virus. Clin Vaccine Immunol 19:1980-3
Czakó, Rita; Atmar, Robert L; Opekun, Antone R et al. (2012) Serum hemagglutination inhibition activity correlates with protection from gastroenteritis in persons infected with Norwalk virus. Clin Vaccine Immunol 19:284-7
Bernstein, David I; El Sahly, Hana M; Keitel, Wendy A et al. (2011) Safety and immunogenicity of a candidate parvovirus B19 vaccine. Vaccine 29:7357-63
Salinas, Jennifer; McCormick, Joseph B; Rentfro, Anne et al. (2011) The missing men: high risk of disease in men of Mexican origin. Am J Mens Health 5:332-40
Kavanagh, Owen; Estes, Mary K; Reeck, Amanda et al. (2011) Serological responses to experimental Norwalk virus infection measured using a quantitative duplex time-resolved fluorescence immunoassay. Clin Vaccine Immunol 18:1187-90
Frenck Jr, Robert W; Belshe, Robert; Brady, Rebecca C et al. (2011) Comparison of the immunogenicity and safety of a split-virion, inactivated, trivalent influenza vaccine (Fluzone®) administered by intradermal and intramuscular route in healthy adults. Vaccine 29:5666-74

Showing the most recent 10 out of 41 publications